Hereditary Gastric Cancer: Review of Literature

1. Barber ME, Save V, Carneiro F, Dwerryhouse S, Lao-Sirieix P, Hardwick RH, Caldas C, Fitzgerald RC: Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk. // J Pathol 2008; 216:286-294.10.1002/path.2415Search in Google Scholar

2. Berx G, Becker KF, Hofler H, van RF: Mutations of the human E-cadherin (CDH1) gene. Hum Mutat // 1998; 12:226-237.10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>3.0.CO;2-DSearch in Google Scholar

3. Blair V, Martin I, Shaw D, Winship I, Kerr D, Arnold J, Harawira P, McLeod M, Parry S, Charlton A, et al.: Hereditary diffuse gastric cancer: diagnosis and management. Clin Gastroenterol Hepatol // 2006; 4:262-275.10.1016/j.cgh.2005.12.003Search in Google Scholar

4. Bosman FT, Carneiro F, Hruban RH, Theise ND: WHO Classification of Tumours of the Digestive System. 4th edition. Lyon, France: IARC; 2010.Search in Google Scholar

5. Carneiro F, Oliveira C, Suriano G, Seruca R: Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer. J Clin Pathol // 2008; 61:25-30.Search in Google Scholar

6. Charlton A, Blair V, Shaw D, Parry S, Guilford P, Martin IG: Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut // 2004; 53:814-820.10.1136/gut.2002.010447Search in Google Scholar

7. Chun YS, Lindor NM, Smyrk TC, Petersen BT, Burgart LJ, Guilford PJ, Donohue JH: Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated? Cancer // 2001; 92:181-187.10.1002/1097-0142(20010701)92:1<181::AID-CNCR1307>3.0.CO;2-JSearch in Google Scholar

8. Cisco RM, Ford JM, Norton JA: Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery. Cancer // 2008; 113:1850-1856.10.1002/cncr.23650Search in Google Scholar

9. Corso G, Pedrazzani C, Pinheiro H, Fernandes E, Marrelli D, Rinnovati A, Pascale V, Seruca R, Oliveira C, Roviello F: E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer // 2011; 47:631-639.10.1016/j.ejca.2010.10.011Search in Google Scholar

10. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P: Cancer Incidence in Five Continents. IARC Scientific Publication // 2007;Search in Google Scholar

11. Drubin DG, Nelson WJ: Origins of cell polarity. Cell 1996; 84:335-34410.1016/S0092-8674(00)81278-7Search in Google Scholar

12. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol // 2007; 18: 581-9210.1093/annonc/mdl498Search in Google Scholar

13. Fitzgerald RC, Hardwick R, Huntsman D, Carneiro F, Guilford P, Blair V, Chung DC, Norton J, Ragunath K, van Krieken JH, et al.: Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet // 2010; 47:436-444.10.1136/jmg.2009.074237Search in Google Scholar

14. Fitzgerald RC, Caldas C: E-cadherin mutations and hereditary gastric cancer: prevention by resection? Dig Dis // 2002; 20:23-31.10.1159/000063162Search in Google Scholar

15. Fitzgerald RC, Caldas C: Clinical implications of E-cadherin associated hereditary diffuse gastric cancer. Gut // 2004; 53:775-778.10.1136/gut.2003.022061Search in Google Scholar

16. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH: Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst // 1994; 86:1600-1608.10.1093/jnci/86.21.1600Search in Google Scholar

17. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE: E-cadherin germline mutations in familial gastric cancer. Nature // 1998; 392:402-405.10.1038/32918Search in Google Scholar

18. Humar B, Guilford P: Hereditary diffuse gastric cancer: a manifestation of lost cell polarity. Cancer Sci // 2009; 100:1151-1157.10.1111/j.1349-7006.2009.01163.xSearch in Google Scholar

19. Huntsman DG, Carneiro F, Lewis FR, MacLeod PM, Hayashi A, Monaghan KG, Maung R, Seruca R, Jackson CE, Caldas C: Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations. N Engl J +-Search in Google Scholar

20. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global Cancer Statistics. A Cancer Journal for Clinicians // 2011; 61: 69-90.10.3322/caac.20107Search in Google Scholar

21. Kaurah P, MacMillan A, Boyd N, Senz J, De LA, Chun N, Suriano G, Zaor S, Van ML, Gilpin C, et al.: Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA // 2007; 297:2360-2372.10.1001/jama.297.21.2360Search in Google Scholar

22. Kluijt I, Sijmons RH, Hoogerbrugge N, Plukker JT, De JD, van Krieken JH, Van HR, Ligtenberg M, Bleiker E, Cats A: Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance. Fam Cancer // 2012; 11:363-369.10.1007/s10689-012-9521-ySearch in Google Scholar

23. La Vecchia C, Negri E, Franceschi S, Gentile A: Family history and the risk of stomach and colorectal cancer. Cancer // 1992; 70:50-55.10.1002/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-ISearch in Google Scholar

24. Lauren P: The two histological main types of gastric carcinoma: diffuse and so-called intestinaltype carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand // 1965; 64:31-49.10.1111/apm.1965.64.1.31Search in Google Scholar

25. Lechler T, Fuchs E: Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature // 2005; 437:275-280.10.1038/nature03922139937116094321Search in Google Scholar

26. Lu B, Roegiers F, Jan LY, Jan YN: Adherens junctions inhibit asymmetric division in the Drosophila epithelium. Nature // 2001; 409:522-525.10.1038/3505407711206549Search in Google Scholar

27. Lynch HT, Grady W, Suriano G, Huntsman D: Gastric cancer: new genetic developments. J Surg Oncol // 2005; 90:114-133.10.1002/jso.2021415895459Search in Google Scholar

28. Miholic J, Meyer HJ, Muller MJ, Weimann A, Pichlmayr R: Nutritional consequences of total gastrectomy: the relationship between mode of reconstruction, postprandial symptoms, and body composition. Surger // 1990; 108:488-494.Search in Google Scholar

29. Nejsum LN, Nelson WJ: A molecular mechanism directly linking E-cadherin adhesion to initiation of epithelial cell surface polarity. J Cell Biol // 2007; 178:323-335.10.1083/jcb.200705094206445017635938Search in Google Scholar

30. Norton JA, Ham CM, Van DJ, Jeffrey RB, Longacre TA, Huntsman DG, Chun N, Kurian AW, Ford JM: CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer. Ann Surg // 2007; 245:873-879.10.1097/01.sla.0000254370.29893.e4187696717522512Search in Google Scholar

31. Oliveira C, Senz J, Kaurah P, Pinheiro H, Sanges R, Haegert A, Corso G, Schouten J, Fitzgerald R, Vogelsang H, et al.: Germline CDH1 deletions in hereditary diffuse gastric cancer families. Hum Mol Genet // 2009; 18:1545-1555.10.1093/hmg/ddp046266728419168852Search in Google Scholar

32. Pisani P, Bray F, Parkin DM: Estimates of the worldwide prevalence of cancer for 25 sites in the adult population. Int J Cancer // 2002; 97:72-81.10.1002/ijc.157111774246Search in Google Scholar

33. Pharoah PD, Guilford P, Caldas C: Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology // 2001; 121:1348-1353.10.1053/gast.2001.2961111729114Search in Google Scholar

34. Sano T, Kobori O, Muto T: Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg // 1992, 79:241-244.10.1002/bjs.18007903191313325Search in Google Scholar

35. Stone J, Bevan S, Cunningham D, Hill A, Rahman N, Peto J, Marossy A, Houlston RS: Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer // 1999; 79:1935-193710.1038/sj.bjc.6690308236277910206317Search in Google Scholar

36. Yamaoka Y, Kato M, Asaka M: Geographic Differences in Gastric Cancer Incidence Can be Explained by Differences between Helicobacter pylori Strains, Inter Med // 2008; 47: 1077-1083. 10.2169/internalmedicine.47.0975373248818552463Search in Google Scholar